Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;12(1):e220194.
doi: 10.2217/cer-2022-0194. Epub 2022 Dec 1.

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10

Alex Simpson  1 , Sreeram V Ramagopalan  1
Affiliations

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10

Alex Simpson et al. J Comp Eff Res. 2023 Jan.

Abstract

In this latest update we discuss the transportability of comparative effectiveness evidence across countries. We highlight results of a survey indicating that European HTA agencies are reluctant to accept real-world data from other countries, review recent benefit assessments indicating a potential softening of a requirement for the use of local real-world data in Germany, and outline a recent review presenting approaches that can correct for a lack of transportability.

Keywords: Europe; HTA; RWE; comparative effectiveness research; health technology assessment; real-world evidence; transportability.

PubMed Disclaimer

Conflict of interest statement

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

References

    1. Hernán MA, Hernández-Díaz S. Beyond the intention-to-treat in comparative effectiveness research. Clin. Trials 9(1), 48–55 (2012). - PMC - PubMed
    1. Westreich D, Edwards JK, Lesko CR, Cole SR, Stuart EA. Target validity and the hierarchy of study designs. Am. J. Epidemiol. 188(2), 438–443 (2019). - PMC - PubMed
    1. Bullement A, Podkonjak T, Robinson MJ et al. Real-world evidence use in assessments of cancer drugs by NICE. Int. J. Technol. Assess. Health Care (2020). https://pubmed.ncbi.nlm.nih.gov/32646531/ - PubMed
    1. Hatswell AJ, Baio G, Berlin JA, Irs A, Freemantle N. Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014. BMJ Open 6(6), e011666 (2016). - PMC - PubMed
    1. Patel D, Grimson F, Mihaylova E et al. Use of external comparators for health technology assessment submissions based on single-arm trials. Value Health 24(8), 1118–1125 (2021). - PubMed

LinkOut - more resources